CRISPR/Cas9-mediated introduction of the sodium/iodide symporter gene enables noninvasive in vivo tracking of induced pluripotent stem cell-derived cardiomyocytes.
Ostrominski JW, Yada RC, Sato N, Klein M, Blinova K, Patel D, Valadez R, Palisoc M, Pittaluga S, Peng KW, San H, Lin Y, Basuli F, Zhang X, Swenson RE, Haigney M, Choyke PL, Zou J, Boehm M, Hong SG, Dunbar CE.
Ostrominski JW, et al. Among authors: klein m.
Stem Cells Transl Med. 2020 Oct;9(10):1203-1217. doi: 10.1002/sctm.20-0019. Epub 2020 Jul 23.
Stem Cells Transl Med. 2020.
PMID: 32700830
Free PMC article.